Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma

NCT00669877 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Burkitt's Lymphoma
Burkitt'S-like Lymphoma

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: G-CSF
DRUG: Cytarabine
DRUG: Methotrexate

Sponsor

M.D. Anderson Cancer Center